V8 Peptides — Engineered Performance

Research Library

Peptide Research, Explained

Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.

Sex, Age and Menopause Models in Peptide Research
Research CompoundsPreclinical

Sex, Age and Menopause Models in Peptide Research

A study-design guide to sex, age and menopause-model variables in preclinical peptide research: NIH policy, evidence of male bias, ovariectomized rats and reporting standards.

Read article →
NAD+ and Aging Biology: Evidence and Limits
NAD+Preclinical

NAD+ and Aging Biology: Evidence and Limits

A critical map of the NAD+ and aging literature: age-related NAD changes, CD38, sirtuins, measurement methods and the limits of what the studies show.

Read article →
NAD+ in Axon Degeneration and Neurodegeneration Models
NAD+Preclinical

NAD+ in Axon Degeneration and Neurodegeneration Models

A model-by-model guide to NAD+ in neuronal injury research: Wlds and Nmnat, SARM1 NAD+ cleavage, XPA mitophagy and an Alzheimer-type mouse model.

Read article →
Melanotan II Research Models: Cell Lines and Bioassays
Melanotan IIPreclinical

Melanotan II Research Models: Cell Lines and Bioassays

A model-selection guide for melanotan II research: receptor cell lines, pigment-cell bioassays, antagonist-paired designs and rodent feeding models, with controls.

Read article →
MOTS-c and Brown Fat: What Mouse Studies Report
MOTS-cPreclinical

MOTS-c and Brown Fat: What Mouse Studies Report

A careful read of the MOTS-c adipose literature: brown fat activation in an ovariectomy model, AMPK evidence, and the measurements needed to claim thermogenesis.

Read article →
MOTS-c Nuclear Localization: Assays and Controls
MOTS-cPreclinical

MOTS-c Nuclear Localization: Assays and Controls

A methods guide to demonstrating nuclear localization and gene regulation by MOTS-c: fractionation, imaging, AMPK dependence, reporters and peptide controls.

Read article →
Hexarelin and IGF-1: What Preclinical Studies Report
HexarelinPreclinical

Hexarelin and IGF-1: What Preclinical Studies Report

A literature review of what rat, dog and mouse studies report for circulating IGF-1 during hexarelin exposure, why GH release and IGF-1 can diverge, and how to design the measurement.

Read article →
MOTS-c and AMPK: Assays, Tool Compounds and Controls
MOTS-cPreclinical

MOTS-c and AMPK: Assays, Tool Compounds and Controls

A bench guide to testing the MOTS-c AMPK hypothesis: what published studies measured, how AMPK activators and inhibitors behave, and what controls a clean experiment needs.

Read article →
Mitochondrial Peptides: MDPs and Function Assays Guide
Research CompoundsPreclinical

Mitochondrial Peptides: MDPs and Function Assays Guide

A general guide to mitochondrial function in aging research: the roles of the organelle, the main laboratory readouts, and how mitochondrial-derived peptides fit the picture.

Read article →
Melanotan II (MT-2): A Laboratory Handbook
Melanotan IIPreclinical

Melanotan II (MT-2): A Laboratory Handbook

A bench handbook for working with Melanotan II as a reference melanocortin agonist: structure, receptor panels, controls, material checks and documentation.

Read article →
AOD-9604 Metabolic Pathway Assays in the Laboratory
AOD-9604Preclinical

AOD-9604 Metabolic Pathway Assays in the Laboratory

A bench-level map of the assays in which AOD-9604 has been studied: what each measures, what published rodent studies reported, and what controls make the data interpretable.

Read article →
KPV in Tissue Injury and Repair Models: Evidence Map
KPVPreclinical

KPV in Tissue Injury and Repair Models: Evidence Map

A map of the preclinical models in which KPV has been studied as a modulator of tissue injury and inflammation, what each reported, and what a repair-focused study would still need to show.

Read article →
KPV Tripeptide Research Guide: Evidence and Gaps
KPVPreclinical

KPV Tripeptide Research Guide: Evidence and Gaps

Organizes the KPV tripeptide research record into evidence tiers, points to deeper articles for each, lists open questions and gives a paper-reading checklist.

Read article →
KPV and the PepT1 Transporter: Uptake Evidence
KPVPreclinical

KPV and the PepT1 Transporter: Uptake Evidence

Explains PepT1, tissue and cell-line expression, the competition and kinetic evidence for KPV uptake, and a controls-first assay design for cultured cells.

Read article →
KPV and NF-κB Signaling: Evidence by Pathway Step
KPVPreclinical

KPV and NF-κB Signaling: Evidence by Pathway Step

Breaks the KPV and NF-κB literature into pathway steps, shows what each cell and mouse study measured, covers the receptor question, assay choice and limits.

Read article →
KPV in Murine Colitis Models: DSS, TNBS and Transfer
KPVPreclinical

KPV in Murine Colitis Models: DSS, TNBS and Transfer

A model-by-model look at KPV in mouse colitis studies: how DSS, TNBS and transfer colitis differ, what was reported, the endpoints used and what limits comparison.

Read article →
KPV Antimicrobial Properties In Vitro: An Assay Guide
KPVPreclinical

KPV Antimicrobial Properties In Vitro: An Assay Guide

An assay-focused guide to published in vitro KPV antimicrobial results: what was tested, how colony, MIC and membrane assays differ, needed controls and where the evidence stops.

Read article →
KPV in Animal Studies: Published Parameters and Math
KPVPreclinical

KPV in Animal Studies: Published Parameters and Math

A literature-based look at KPV preclinical studies: models, vehicles and routes reported, concentration arithmetic as formulas, and questions to settle before any lab protocol.

Read article →
Ipamorelin Research Profile: Identity and Evidence
IpamorelinPreclinical

Ipamorelin Research Profile: Identity and Evidence

A scannable ipamorelin research profile: identity card, evidence map by model system, comparisons and open questions.

Read article →
Ipamorelin Pharmacokinetics: Half-Life Math and Studies
IpamorelinPreclinical

Ipamorelin Pharmacokinetics: Half-Life Math and Studies

Ipamorelin pharmacokinetics from primary sources: reported half-life, clearance, first-order formulas and matrix stability design.

Read article →
IGF-1 and Tissue Repair Research: What Models Show
IGF-1 LR3Preclinical

IGF-1 and Tissue Repair Research: What Models Show

A literature-based look at IGF-1 in tissue repair models: myotube hypertrophy, transgenic and gene-delivery mouse studies, rat anabolic studies with IGF-1 variants, and the limits of extrapolation.

Read article →
IGF-1 LR3 Complete Guide: Where the Research Fits
IGF-1 LR3Preclinical

IGF-1 LR3 Complete Guide: Where the Research Fits

A one-stop orientation to IGF-1 LR3 research: the IGF system, the analog's design, the main laboratory uses, how to read papers about it and which questions each article in the library answers.

Read article →
IGF-1 LR3 Half-Life: What Published Studies Report
IGF-1 LR3Preclinical

IGF-1 LR3 Half-Life: What Published Studies Report

What 'half-life' means for IGF-1 LR3 in a laboratory context: binding-protein reservoirs, persistence in culture medium, how analog design changes it, and why it is not shelf life.

Read article →
Hexarelin Side Effects in Research: What Studies Report
HexarelinPreclinical

Hexarelin Side Effects in Research: What Studies Report

What the published hexarelin literature reports beyond GH release, which readouts to plan for in a model system, and the vial-related artifacts that can be mistaken for biological effects.

Read article →

84 articles in Preclinical